-
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
24 Oct 2021 16:24 GMT
… were among the healthcare initial public offerings that were priced during … ) (before the market open)
Alimera Sciences, Inc. (NASDAQ: ALIM) … before the market open)
IPOs
IPO Pricing
Princeton, New Jersey- … million shares in an IPO. The Marlborough, …
-
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
24 Feb 2021 20:04 GMT
… . (NASDAQ: ACAD) (after the close)
Alimera Sciences Inc (NASDAQ: ALIM) (after the … (NASDAQ: GTHX) (after the close)
IPO
BriaCell Therapeutics Corp., a clinical …
-
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
25 Oct 2020 18:52 GMT
… . (NASDAQ: AMGN) (after the close)
Alimera Sciences Inc (NASDAQ: ALIM) (after the … : LGND) (before the market open)
IPOs
Boulder, Colorado-based Biodesix, Inc … .17 million shares in an initial public offering, or IPO, at an estimated price …
-
Georgia Bio Deals of the Year Spotlight Financings, Acquisitions and IPO
18 Jan 2017 16:09 GMT
… categories – private financing, initial public offering,
public financing, and acquisitions … awards.
The recipients are: Alimera Sciences, Inc.; Arbor Pharmaceuticals, … 47;.
Public Financing
Alimera
Sciences, Inc.
Alimera Sciences, a pharmaceutical company …
-
Exclusive: Route raises $40 million Series C at a $1.4 billion valuation
25 Jun 2024 14:19 GMT
… been viewed as a bellwether IPO candidate (and a controversial one … (NASDAQ: ANIP) agreed to acquire Alimera Sciences (NASDAQ: ALIM), a Alpharetta, Ga … company, for approximately $381 million.
IPOS
- Alumis, a San Francisco …
-
CFOs on the Move – Q1 2024 Unwrapped
02 Apr 2024 06:30 GMT
… fitness center operator.
(January 2) Alimera Sciences hired Elliot Maltz as the … and leading the company’s IPO on the New York Stock … led Sunnova Energy through its IPO in 2019.
(February 2) BP …
-
92 Biggest Movers From Friday
08 Nov 2021 09:18 GMT
… Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares … .03 following upbeat Q3 results.
Alimera Sciences, Inc. (NASDAQ: ALIM) gained 26 … to close at $5.70. Alimera Sciences Director James R Largent acquired …
-
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
12 Feb 2021 01:23 GMT
… )
Agios Pharmaceuticals Inc (NASDAQ: AGIO)
Alimera Sciences Inc (NASDAQ: ALIM)
Alkermes Plc … )
IPOs
Durham, North Carolina-based Bioventus Inc. priced its upsized initial public offering of …
-
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
28 Oct 2020 12:01 GMT
… . (NASDAQ: AMGN) (after the close)
Alimera Sciences Inc (NASDAQ: ALIM) (after the … (NASDAQ: GNMK) (after the close)
IPOs
Boulder, Colorado-based Biodesix, Inc … solutions company, priced its downsized initial public offering of 4 million shares at …
-
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
28 Oct 2021 13:15 GMT
… , Roche Await FDA Decisions And IPOs
Pfizer, BioNTech Receive Additional 50M … : LH) (before the market open)
Alimera Sciences, Inc. (NASDAQ: ALIM) (before the …
About
© 1995-2025